Hashimoto’s and Graves’ disease are not completely different diseases at the immune level—they are part of a continuous spectrum of immune responses in the thyroid, with similar patterns of immune cell organization in both.
Claim Context
Thyroid autoimmune diseases, including Hashimoto’s thyroiditis and Graves’ disease, exist along a shared spectrum of immune infiltration rather than as two distinct immunological entities, based on consistent patterns of cellular organization across patients.
“HT and GD exhibit convergent cellular dynamics resulting in a shared continuum of immune infiltration. These findings of a shared disease continuum characterized by spatially defined immune niches provide a new framework for understanding tissue homeostasis in human autoimmune disease.”
Evidence from Studies
No evidence studies found yet.
What Would Prove This
Per GRADE and EBM methodology, here is what ideal scientific evidence would look like to definitively prove or disprove this claim, ordered from strongest to weakest.
Whether immune cell profiles in thyroid tissue consistently form a continuous gradient across patients with Hashimoto’s, Graves’, and intermediate phenotypes, rather than discrete clusters.
A systematic review and meta-analysis of all published single-cell and spatial transcriptomic datasets from human thyroid tissue in HT, GD, and mixed phenotypes, using standardized clustering and dimensionality reduction to test whether disease states form a continuous trajectory or discrete clusters.
Whether experimental modulation of immune responses in one disease shifts the immune profile toward the other disease’s pattern.
A double-blind, placebo-controlled trial in 80 patients with early Graves’ disease, randomized to receive a TSH receptor-blocking agent vs. placebo, with serial thyroid biopsies at 0, 6, and 12 months to assess whether immune profiles shift toward those seen in Hashimoto’s.
Whether patients initially diagnosed with one disease develop immune profiles resembling the other disease over time.
A prospective cohort study following 300 patients with newly diagnosed Hashimoto’s or Graves’ disease for 10 years, with annual immune profiling of thyroid tissue (via fine-needle aspiration and single-cell sequencing) to track whether immune signatures evolve toward the other disease’s profile.
Whether patients with intermediate clinical phenotypes (e.g., euthyroid with high TPO antibodies) have immune profiles intermediate between classic HT and GD.
A case-control study comparing immune profiles in 150 patients: 50 with classic Hashimoto’s, 50 with classic Graves’, and 50 with mixed or transitional phenotypes (e.g., euthyroid with high TPO and TSHR antibodies), using standardized single-cell analysis of thyroid tissue.
Whether immune profiles in thyroid tissue form a continuous gradient rather than discrete clusters when comparing patients with Hashimoto’s, Graves’, and non-autoimmune controls.
A cross-sectional analysis of 200 thyroidectomy specimens: 100 HT, 100 GD, with blinded, standardized single-cell RNA sequencing and UMAP clustering to assess whether disease states form discrete clusters or a continuous trajectory.